To validate the KD role of VGF in AD pathogenesis and progression (Fig. 1f), we modulated VGF levels in the transgenic 5xFAD amyloidopathy mouse model (expressing human Presenilin1 (PS1) and APP containing five FAD mutations)41. Here, APP is linked to Alzheimer disease.